Skip to main content
User account menu
Log in
X
Main navigation
Specialties
Alzheimer Disease
Behavioral Neurology
Migraine
Multiple Sclerosis
Neuroimmunology
Neuromuscular Disorders
Pain Medicine
Parkinson Disease
Seizures
Sleep Medicine
Spinal Disorders
Stroke & Vascular
Traumatic Brain Injury
Resources
News
Expert Insights
Interactive Features
Interviews
Neurology Advances
Partner Spotlight
Podcasts
Videos
Excellence Forums
Alzheimer Disease
Behavioral Neurology
Migraine
Multiple Sclerosis
Pain Medicine
Parkinson Disease
Seizures
Sleep Medicine
Stroke & Vascular
Traumatic Brain Injury
Meetings
AAN Annual Meeting
AAN Sports Concussion Conference
AES Annual Meeting
AHS Annual Scientific Meeting
ANA Annual Meeting
APSS SLEEP 2020
Alzheimer's Association International Conference
CMSC Annual Meeting
ECTRIMS/ACTRIMS Joint Triennial Meeting
MDS Congress
CME
Migraine 360
Program Listing
About
Contact Us
Editorial Advisory Board
Editorial Description
Search
Search
Advances
Ozanimod Yields Positive Cognitive Results in SUNBEAM and DAYBREAK Studies
In an analysis of the SUNBEAM and DAYBREAK studies, researchers aimed to compare the effects of ozanimod and intramuscular interferon on Symbol Digit Modalities Test scores among patients aged 18 to 55 years with relapsing multiple sclerosis.
